Study of bone mineral density and serum bone turnover markers in newly diagnosed systemic lupus erythematosus patients.
- Author:
Hai Hong YAO
1
;
Su Mei TANG
1
;
Zhi Min WANG
1
;
Xia ZHANG
1
;
Xu Yong CHEN
1
;
Li GAO
1
;
Jing LIU
1
;
Yi Jun DAI
1
;
Zhao Heng HU
2
;
Xue Wu ZHANG
1
;
Zhan Guo LI
1
Author Information
1. Department of Rheumatology and Immunology, Peking University People's Hospital,Beijing 100044, China.
2. Department of Endocrinology, Peking University People's Hospital,Beijing 100044, China.
- Publication Type:Journal Article
- MeSH:
Absorptiometry, Photon;
Adult;
Bone Density;
Bone Diseases, Metabolic;
Bone Remodeling;
Female;
Humans;
Lupus Erythematosus, Systemic/physiopathology*;
Male;
Middle Aged;
Young Adult
- From:
Journal of Peking University(Health Sciences)
2018;50(6):998-1003
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the changes of bone mineral density (BMD) and serum bone turnover factor in newly diagnosed systemic lupus erythematous (SLE) patients.
METHODS:Eighty newly diagnosed SLE patients and 80 age and gender matched healthy controls were enrolled. None of the SLE patients had ever received glucocorticoid, immunosuppressive agents or vitamin D. BMD was measured at radius,lumbar spine and hip by dual X ray absorptiometry (DXA). Bone turnover markers including serum levels of tartrate-resistant acid phosphatase 5b (TRAP5b),bone alkaline phosphatase (BAP) and 25-hydroxy vitamin D3 (25-OH-VD3) were measured by enzyme-linked immunosorbent assay (ELISA). Logistic regression was employed to analyze the risk factors associated with decreased BMD.
RESULTS:Mean age of the SLE patients was (32.8±12.4) years, and 85% were female, none of whom were post-menopausal. BMD was significantly reduced in all the measured sites, compared with the healthy controls. Sixteen (20%) of the patients were osteopenic in at least one site measured locations. The serum levels of 25-OH-VD3 were markedly reduced in the newly diagnosed SLE patients than those of the normal controls [(46.1+12.3) nmol/L vs. (25.4+11.2) nmol/L, P<0.001)]. The serum levels of 25-OH-VD3 in the SLE patients with nephritis were much lower than those without nephritis (P=0.04). A significant negative correlation was demonstrated between the serum concentration of 25-OH-VD3 and the disease activity scores as measured by SLE disease activity index (SLEDAI) (r=-0.3,P=0.001). The serum TRAP5b concentration was positively correlated with SLEDAI (r=0.435,P=0.003). Age (P=0.058) and SLEDAI (P=0.085) were probably associated with decreased BMD in Logistic regression analysis.
CONCLUSION:The study showed reduced BMD in untreated SLE patients. The role of chronic inflammation was of probable importance in bone metabolism.
